module 3- d- antipsychotics for bipolar disorder

Upload: psychopharmacology

Post on 04-Apr-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    1/19

    Module 3Indications for Antipsychotics

    Bipolar DisorderFlavio Guzmn, MD

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    2/19

    Outline

    Indications of antipsychotics in differentphases of bipolar disorder: Mania/mixed states

    Bipolar depression

    Maintenance treatment

    FDA approved agents for each phase

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    3/19

    Use of antipsychotics in bipolar diso

    Bipolar depression

    Mania Mixed states

    Mainte

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    4/19

    Mania Management

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    5/19

    Acute mania pharmacother

    Patients with BD spend much less time mania, hypomania, or mixed states tha

    do in depression.

    Many effective treatments for mania, fefor maintenance treatment or treatmen

    bipolar depression.

    Schatzberg, AF., Cole, JO, and DeBattista, C. Manual of ClinicaPsychopharmacology. 7th ed.American Psychiatric Publishing

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    6/19

    Acute mania pharmacother

    FGAs SGAs

    Anticonvulsants Lithium

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    7/19

    Antipsychotics for mania

    FGAs are effective in the treatment of mbut are frequently avoided due to the r

    EPS.

    Antipsychotics work as well as lithium iacute mania, even in the absence of

    psychotic symptoms.

    Schatzberg, AF., Cole, JO, and DeBattista, C. Manual of ClinicaPsychopharmacology. 7th ed.American Psychiatric Publishing

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    8/19

    FGAs treatment

    Patients with mood disorders might mo

    vulnerable to developing TD than

    schizophrenia patients.

    Schatzberg, AF., Cole, JO, and DeBattista, C. Manual of ClinicaPsychopharmacology. 7th ed.American Psychiatric Publishing

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    9/19

    Mixed Episodes

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    10/19

    FDA approved SGAs for

    manic/mixed episodes

    Manic/mixed ep

    Aripiprazole

    Asenapine

    Quetiapine andquetiapine XR

    Risperidone Olanzapine

    Ziprasidone

    Frye MA. Clinical practice. Bipolar disorder--a focus on depression

    N Engl J Med. 2011;364(1):51-9.

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    11/19

    The role of SGAs in the treatment of manic/mixed e

    Manic/mixed episodes

    Aripiprazole

    Asenapine

    Quetiapine and quetiapine XR

    Risperidone

    Olanzapine

    Ziprasidone

    Manic/mixed episodes

    Aripiprazole

    Asenapine

    Quetiapine and quetiapine XR

    Risperidone

    Olanzapine

    Ziprasidone

    LithiumD

    Approved as

    monotherapy

    Approved as

    adjunctive

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    12/19

    Bipolar Depression

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    13/19

    Bipolar depression

    Depression is the predominant mood stbipolar disorder.

    Some clinicians argue that this state is t

    most difficult to treat. There are few proven strategies for bip

    depression.

    Schatzberg, AF., Cole, JO, and DeBattista, C. Manual of ClinicaPsychopharmacology. 7th ed.American Psychiatric Publishing

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    14/19

    Bipolardepression

    Quetiapine

    Olanzapine/

    fluoxetine

    FDA approved SGAs forbipolar depression

    Frye MA. Clinical practice. Bipolar disorder--a focus on depression

    N Engl J Med. 2011;364(1):51-9.

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    15/19

    Maintenance treatment

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    16/19

    Maintenanctreatment

    Aripiprazole

    Olanzapine

    Quetiapine anquetiapine XR

    Risperidone (L

    Ziprasidone

    FDA approved SGAs for

    maintenance

    treatment

    Frye MA. Clinical practice. Bipolar disorder--a focus on depression

    N Engl J Med. 2011;364(1):51-9.

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    17/19

    Maintenance treatment: SG

    Advantages

    Titration is rapid andeasier. (Compared to

    lamotrigine andlithium)

    Safer in overdose

    Disadvantage

    Weight gain

    Metabolic side

    effects Sedation

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    18/19

    Take home points

    Antipsychotics are effective for mania, mistates and bipolar depression.

    Bipolar depress

    Quetiapine

    Olanzapine /fluoxetine

    Manic/mixed episodesc

    Aripiprazole

    Asenapine

    Quetiapine andquetiapine XR

    Risperidone

    Olanzapine

    Ziprasidone

    Maintenancetreatment

    AripiprazoleOlanzapine

    Quetiapine andquetiapine XR

    Risperidone (LAI)

    Ziprasidone

  • 7/31/2019 Module 3- D- Antipsychotics for Bipolar Disorder

    19/19

    References and further read

    Frye MA. Clinical practice. Bipolardisorder--a focus on depression. N EnglMed. 2011;364(1):51-9.

    Schatzberg, AF., Cole, JO, and DeBattist

    C. Manual of ClinicalPsychopharmacology. 7th ed.AmericanPsychiatric Publishing, 2010.